By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
PR Newswire TAMPA, Fla., Nov. 26, 2024 TAMPA, Fla., Nov. 26, 2024 /PRNewswire/ -- This Thanksgiving week, the Obesity Action Coalition (OAC) extends its gratitude to the Biden Administration for proposing a new rule significantly expanding ...
PR Newswire REYKJAVIK, Iceland, Nov. 12, 2024 REYKJAVIK, Iceland, Nov. 12, 2024 /PRNewswire/ -- New study from deCODE genetics/Amgen highlights the importance of BMI in pathogenesis of disease, suggesting that reducing BMI alone could lower ...
PR Newswire BEIJING, Nov. 11, 2024 BEIJING, Nov. 11, 2024 /PRNewswire/ -- Gan & Lee Pharmaceuticals (Gan & Lee, Shanghai Stock Exchange: 603087) announced that the results of the Phase 2b clinical study of GZR18 injection, a bi-weekly (twice ...
Canada NewsWire EDMONTON, AB, Nov. 7, 2024 Obesity has reached significant levels, where nearly one in three Canadians live with the chronic disease Top-line findings emphasize urgent need for Canada-wide public health strategies ...
PR Newswire HONG KONG, Nov. 7, 2024 HONG KONG, Nov. 7, 2024 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX:1672, "Ascletis") announces topline results of its Phase I single ascending dose (SAD) study in Australia in subjects with elevated ...
PR Newswire SEOUL, South Korea, Nov. 6, 2024 Fat Loss Augmentation + Lean Mass Increase Hanmi Presents Three Breakthrough Findings on Novel Obesity Drugs at 2024 ObesityWeekHigh Quality Obesity Management by Targeting the CRF2 Receptor: ...
PR Newswire BEVERLY HILLS, Calif., Nov. 4, 2024 Dr. David Davtyan, a renowned bariatric surgeon in Los Angeles, has been awarded the prestigious title of Fellow of the American Society for Metabolic & Bariatric Surgery (FASMBS) in ...
PR Newswire THE HAGUE, Netherlands, Nov. 4, 2024 Affidea introduces the Roczen platform from Reset Health for the management of obesity and type 2 diabetes, offering personalised care, GLP-1 medications, and improved health outcomes for ...
PR Newswire SAN DIEGO, Nov. 4, 2024 Up to 6.8% Placebo-Adjusted Mean Weight Loss (8.2% from Baseline) After 28 Days of Dosing with Oral Tablet of VK2735 Encouraging Tolerability Through 100 mg Daily Dosing with Oral VK2735; Mild ...
PR Newswire MONTREAL, Nov. 3, 2024 - Congruence has been awarded the Neuroscience Section Blitz Talk Award for transformative research in MC4R-related early-onset genetic obesity - - Congruence's insights into the biology and ...
Understanding how brain chemistry and food decisions are linked to rising obesity and related health issues.
Study finds a 50% rise in overweight and obesity among adolescents in England, increasing from 22% in 2008–2010 to 33% in 2021–2023.
The increasing use of GLP-1 medications for weight loss is leading to significant changes in food preferences, with users consuming less processed foods, soda, and certain meats.
Losing a lot of weight provides long-term health benefits, even if some weight is regained.
A new study links childhood overweight and obesity to higher COPD risk, stressing early weight management for lung health.
Subscribe to our Free Newsletters!